ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
cgt2009
|
65 |
21K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
65
|
21K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
cgt2009
|
65 |
21K |
0 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
65
|
21K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Symposium
|
|
cgt2009
|
20 |
6.7K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
20
|
6.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
What’s next???
|
|
cgt2009
|
14 |
4.0K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
14
|
4.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Updated 30-day DurAVR THV Clinical Data
|
|
cgt2009
|
27 |
8.4K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
27
|
8.4K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
cgt2009
|
65 |
21K |
7 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
65
|
21K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Preliminary Final Report
|
|
cgt2009
|
10 |
4.9K |
14 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
10
|
4.9K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
cgt2009
|
32 |
11K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
32
|
11K
|
2
|
|
World Politics
|
|
Re:
Russia Ukraine war
|
|
cgt2009
|
212K |
25M |
3 |
30/01/24 |
30/01/24 |
World Politics
|
212K
|
25M
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
cgt2009
|
29 |
9.2K |
2 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
29
|
9.2K
|
2
|
|
World Politics
|
|
Re:
Russia Ukraine war
|
|
cgt2009
|
212K |
25M |
4 |
30/01/24 |
30/01/24 |
World Politics
|
212K
|
25M
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
cgt2009
|
29 |
9.2K |
8 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
29
|
9.2K
|
8
|
|
World Politics
|
|
Re:
Russia Ukraine war
|
|
cgt2009
|
212K |
25M |
1 |
29/01/24 |
29/01/24 |
World Politics
|
212K
|
25M
|
1
|
|
World Politics
|
|
Re:
Russia Ukraine war
|
|
cgt2009
|
212K |
25M |
3 |
28/01/24 |
28/01/24 |
World Politics
|
212K
|
25M
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
cgt2009
|
29 |
9.2K |
4 |
28/01/24 |
28/01/24 |
ASX - By Stock
|
29
|
9.2K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Next Gen DurAVR
|
|
cgt2009
|
11 |
3.5K |
1 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
11
|
3.5K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Next Gen DurAVR
|
|
cgt2009
|
11 |
3.5K |
3 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
11
|
3.5K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Next Gen DurAVR
|
|
cgt2009
|
11 |
3.5K |
1 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
11
|
3.5K
|
1
|
|
ASX - By Stock
|
AVR |
Next Gen DurAVR
|
|
cgt2009
|
11 |
3.5K |
12 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
11
|
3.5K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
cgt2009
|
29 |
9.2K |
3 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
29
|
9.2K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
cgt2009
|
29 |
9.2K |
1 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
29
|
9.2K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Share Price Uncertainty
|
|
cgt2009
|
1 |
771 |
3 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
1
|
771
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
5 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
200
|
55K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
1 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
200
|
55K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
4 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
200
|
55K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
3 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
200
|
55K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
3 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
200
|
55K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
3 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
200
|
55K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
4 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
200
|
55K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
2 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
200
|
55K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
5 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
200
|
55K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
5 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
200
|
55K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
2 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
200
|
55K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
cgt2009
|
28 |
7.6K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
cgt2009
|
28 |
7.6K |
3 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.6K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
cgt2009
|
28 |
7.6K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
cgt2009
|
66 |
20K |
7 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
66
|
20K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
cgt2009
|
66 |
20K |
16 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
66
|
20K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
cgt2009
|
200 |
55K |
5 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
200
|
55K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
cgt2009
|
66 |
20K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
20K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
cgt2009
|
66 |
20K |
20 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
20K
|
20
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
cgt2009
|
74 |
23K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
74
|
23K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
cgt2009
|
74 |
23K |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
74
|
23K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
cgt2009
|
74 |
23K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
74
|
23K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
cgt2009
|
74 |
23K |
3 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
74
|
23K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
cgt2009
|
74 |
23K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
74
|
23K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
cgt2009
|
74 |
23K |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
74
|
23K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
TAVR MARKET Superiority
|
|
cgt2009
|
87 |
29K |
1 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
87
|
29K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
TAVR MARKET Superiority
|
|
cgt2009
|
87 |
29K |
3 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
87
|
29K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
cgt2009
|
116 |
30K |
6 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
116
|
30K
|
6
|
|